For those seeking an effective, multi-faceted approach to appetite suppression and weight loss, PhenQ stands out as the ...

Let us have a closer look at the formula and the truth behind these claims in this Flush Factor Plus review. This review ...

The patent application covers the use of 3-Methylmethcathinone (3-MMC) in combination with Palmitoylethanolamide (PEA). This innovative combination aims to address the complex neurobiological and ...

Presentation will take place during the “Developmental Therapeutics - Immunotherapy” session on May 31, 2025, from 3:00 – 6:00pm CT at McCormick Place, Chicago ...

The study was designed to assess local tolerance and tissue response following a 4-hour application of a formulation of PL-14, a mucoadhesive nasal gel spray formulated to act as a physical barrier ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway ...

BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes ...

BioPorto announces completion of an oversubscribed directed offering of 25 million new shares raising DKK 33.5 million ...

Bottom Line: If you’re serious about burning more fat, feeling energized, and taking control of your body composition, PhenQ ...

The Stock Option is being granted as an inducement material to Mr. Poma entering into employment with the Company in accordance with Section 711 of NYSE American LLC Company Guide. Calidi ...

To celebrate the launch, Codetta is inviting researchers to be a part of “ The Opening Concerto ”—an exclusive early access program for the first 50 organizations or individuals who sign up at booth ...

VYNE has suspended all screening, enrollment and patient dosing in the Phase 1b trial of VYN202 and intends to work diligently with the FDA to resolve the clinical hold as soon as possible. To date, ...